HEATHER JONES: Open Payments
NPI 1992585459 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,146 in 43 payments from 12 companies in 2025. Trend: 2023 $232 · 2024 $2,565 · 2025 $1,146
Food & beverage: $1,047Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $323 |
| Sumitomo Pharma America, Inc. | 8 | $178 |
| ABBVIE INC. | 8 | $147 |
| MAYNE PHARMA COMMERCIAL LLC | 7 | $145 |
| Exeltis, USA Inc. | 1 | $118 |
| Biogen, Inc. | 4 | $88 |
| MILLICENT US INC | 2 | $40 |
| SHIELD THERAPEUTICS INC | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
Products named: Veozah, GEMTESA, BOTOX, TWIRLA, ANNOVERA, ZURZUVAE, ACCRUFER, INTRAROSA.
Industry payments across AR — which companies pay providers there.
